HERBS FOR HEALTH MANAGEMENT

Herbs are a foundational root in medicine and health treatments, dating back thousands of years throughout every culture around the world. Modern Western herbalism comes from ancient Egypt. The Greeks developed a comprehensive philosophy of herbal medicine by 100 BCE and the Romans built upon it to create a variety of medical practices, some of which are still used today.

….FULL ARTICLE

ALTERNATIVE MEDICINE IMPACTS PSYCHOLOGICAL HARDINESS

Psychological hardiness is an individual’s resistance to stress, anxiety and depression. It includes the ability to withstand grief and accept the loss of loved ones. Alternative medicine is a more popular term for health and wellness therapies that have typically not been part of conventional Western medical approaches but are often used along with conventional medicinal protocols.  Coping and dealing with stress in a positive manner play a major role in maintaining the balance needed for health and well-being.

….FULL ARTICLE

ALTERNATIVE REMEDIES FOR ANXIETY AND DEPRESSION

Interest in complimentary and alternative medicine (CAM) is increasing as consumers and health care professionals search for additional ways to treat anxiety, depression and other mental health disorders. Some of these remedies include:

St. John’s Wort.  More than 30 studies show it to be effective for treatment of mild forms of depression,…

….FULL ARTICLE

Use the buttons below to scroll through more great articles on health and wellness issues

MORE ARTICLES

Be Sociable, Share!

Share on Facebook Share on Twitter Share on Delicious Share on Digg Share on Google Bookmarks Share on LinkedIn Share on LiveJournal Share on Newsvine Share on Reddit Share on Stumble Upon Share on Tumblr

MORE FEATURE ARTICLES

CONTACT INFORMATION

© Health & Wellness Magazine - All rights reserved | Designed and Maintained by Aurora Automations LLC.

MORE FROM ROCKPOINT PUBLISHING

HEALTH & WELLNESS MAGAZINE

HOME | FEATURE ARTICLES | COLUMNS | DIGITAL ISSUES | BLOG | RACE RUNNING CALENDAR | ABOUT | CONTACT

Continued approval for Aduhelm as a treatment for Alzheimer’s disease may be contingent upon verification of clinical benefit in confirmatory trials. If it fails to show a clinical benefit, the FDA can take it off the market.

NEW TREATMENT AVAILABLE FOR ALZHEIMERS DISEASE

Ten out of 11 members of an expert panel the FDA consulted voted against approval. They questioned if enough evidence was available to support its potential benefits.


Aduhelm is given as an intravenous infusion once a month. Each infusion takes about an hour to administer. Side effects may include temporary swelling in the brain, headache, dizziness, nausea, confusion and vision changes. Rarely, someone may have an allergic to the medication, including swelling of the face, lips, mouth, or tongue and hives.


“We believe this first-in-class medicine will transform the treatment of people living with Alzheimer’s disease and spark continuous innovation in the years to come,” said Biogen CEO Michel Vounatsos. “We are grateful for the contributions of thousands of patients and caregivers who participated in our clinical trials, as well as for the dedication of our scientists and researchers. Together with the healthcare community, we are ready to bring this new medicine to patients and begin to address this growing global health crisis.”

The U.S. Food and Drug Administration (FDA) recently approved Aduhelm (aducanumab-avwa), a new medication to help treat Alzheimer’s disease, through its accelerated approval pathway. Current Alzheimer’s medications only help with symptoms. Aduhelm is the first to treat the underlying disease process. It is manufactured by Biogen, and it was developed in partnership with Eisai, a Tokyo-based pharmaceutical company. It is the first new Alzheimer’s disease treatment offered since 2003.


According to Biogen, Aduhelm is a monoclonal antibody therapy – lab-made antibodies that attack certain cells – that is directed against beta-amyloid plaques, a buildup of protein fragments in the brain. These plaques are widely thought to influence the disease’s progression. As Alzheimer’s worsens with time, the plaques spread across the cortex and affect how cells signal each other. Aduhelm attacks the plaques, lowering the amount of them present in the brain and hopefully stopping them from causing widespread damage.


Aduhelm has only been studied in people with mild cognitive impairment or mild dementia resulting from Alzheimer’s. The FDA did not put any restrictions on who can receive the new medication.


The approval of Aduhelm has not been without controversy.